Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Urology Case Reports|September 22, 2017
Patient with antiphospholipid syndrome presenting with testicular torsion-like symptomsArnav Srivastava, Joan Ko, Joy Ogunsile, et al.
Blood Advances|August 30, 2021
Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remissionSenthil Sukumar, Max Brodsky, Sarah Hussain, et al.
Transfusion|November 12, 2020
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individualsAngela Liu, Noor Dhaliwal, Harshvardhan Upreti, et al.
Blood Advances|July 16, 2021
Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand diseaseKathryn E Dane, John P Lindsley, Thomas Kickler, et al.
Stem Cell Research|April 12, 2017
Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL geneSenquan Liu, Zhaohui Ye, Yongxing Gao, et al.
British Journal of Haematology|June 7, 2014
Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutationElizabeth Hexner, Gail Roboz, Ron Hoffman, et al.
American Journal of Hematology|May 26, 2017
Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertensionChristopher R Reilly, Daria V Babushok, Karlyn Martin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 20, 2023
Overcoming challenges in managing a high-risk pregnancy with placenta previa and newly diagnosed Bombay phenotypeTayler A Van Denakker, Kathy Haddaway, Alyssa Cunningham, et al.
Leukemia|December 21, 2022
Recurrent germline variant in ATM associated with familial myeloproliferative neoplasmsEvan M Braunstein, Eddie Imada, Sergiu Pasca, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia VeraAlexander Coltoff, Ruben Mesa, Jason Gotlib, et al.
Pageof 2